- W Stuart A Smellie, consultant (info@smellie.com)1
- 1 Clinical Laboratory, General Hospital, Bishop Auckland DL14 6AD
- Accepted 23 December 2005
One of the difficulties in addressing the large differences in use of laboratory tests1 is to produce robust protocols, supported by high level evidence, for the use of these tests. A working group has been established to improve the knowledge base in laboratory medicine and is working with Sir Muir Gray, director of clinical knowledge, process and patient safety for the National Programme for Information Technology.2 The initiative has brought together contributions from a range of professional associations and clinical authors to improve knowledge in the use of laboratory testing. It is collating answers to about 100 frequently asked questions in primary care on the use of laboratory tests and is presenting these through a range of media, using a standardised literature search targeted towards clinical guidelines and evidence based reviews. The complete question-answer sets are being developed into prompts, reminders, and alerts to help doctors and nurses while they are treating patients. This series of articles has been constructed around relevant clinical cases which illustrate some of the problems that can arise in using, or not using, laboratory tests, linked to the guidance points obtained from these answers.
The key points are a synthesis of existing guidelines on the subjects concerned, and in most cases originate from the consensus of national or international experts. They are “the best we can get” at present, although the answering process has revealed questions that justify further research and could have a large impact on policies for use of tests. To enrich this debate, guidance is accompanied by evidence notes highlighting the strengths or weaknesses of the evidence base supporting the guidance.
This article presents and discusses two typical cases seen in a district hospital lipid clinic. Laboratories differ in the profiles of tests they offer, and some will add tests …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012